BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12352895)

  • 1. Sirolimus-induced leukocytoclastic vasculitis.
    Hardinger KL; Cornelius LA; Trulock EP; Brennan DC
    Transplantation; 2002 Sep; 74(5):739-43. PubMed ID: 12352895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal leukocytoclastic vasculitis: an adverse effect of sirolimus.
    Nagarajan S; Friedrich T; Garcia M; Kambham N; Sarwal MM
    Pediatr Transplant; 2005 Feb; 9(1):97-100. PubMed ID: 15667620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-induced leukocytoclastic vasculitis: the second case reported.
    Pasqualotto AC; Bianco PD; Sukiennik TC; Furian R; Garcia VD
    Am J Transplant; 2004 Sep; 4(9):1549-51. PubMed ID: 15307846
    [No Abstract]   [Full Text] [Related]  

  • 4. Cinacalcet-induced leukocytoclastic vasculitis.
    Giannikopoulos G; Zorzou MP; Stamoulis I; Panagi G; Sitaras P; Georgopoulos I; Hadjileontis C; Malakos I; Kyriazis J
    Am J Kidney Dis; 2009 Aug; 54(2):e5-8. PubMed ID: 19560849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of glyburide-induced leukocytoclastic vasculitis.
    Henley JK; Blackmon JA; Fraga GR; Rajpara A; Maz M
    Dermatol Online J; 2013 Sep; 19(9):19619. PubMed ID: 24050293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature.
    Yee KW; Hymes SR; Heller L; Prieto VG; Welch MA; Giles FJ
    Leuk Lymphoma; 2006 May; 47(5):926-9. PubMed ID: 16753882
    [No Abstract]   [Full Text] [Related]  

  • 7. Levetiracetam-induced leukocytoclastic vasculitis.
    Gupta M
    Indian J Pharmacol; 2017; 49(1):124-126. PubMed ID: 28458437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-induced acneiform eruption.
    Kunzle N; Venetz JP; Pascual M; Panizzon RG; Laffitte E
    Dermatology; 2005; 211(4):366-9. PubMed ID: 16286750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus.
    Schaffellner S; Jakoby E; Kniepeiss D; Stadlbauer V; Duller D; Iberer F; Tscheliessnigg KH
    Int Immunopharmacol; 2005 Jan; 5(1):137-40. PubMed ID: 15589473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.
    Dean R; Messer AM; Pickett M; Jahan-Tigh R
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.
    Kahan BD; Podbielski J; Napoli KL; Katz SM; Meier-Kriesche HU; Van Buren CT
    Transplantation; 1998 Oct; 66(8):1040-6. PubMed ID: 9808489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis: another coumarin-induced hemorrhagic reaction.
    Tamir A; Wolf R; Brenner S
    Acta Derm Venereol; 1994 Mar; 74(2):138-9. PubMed ID: 7911622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced vasculitis.
    Duggal MK; Singh A; Arunabh ; Lolis JD; Guzik HJ
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):21-4. PubMed ID: 16089244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotics, purpura and ulcers: a leukocytoclastic vasculitis after clarithromycin].
    Zink A; Erni S; Fliegner M
    Dtsch Med Wochenschr; 2006 Oct; 131(40):2217-20. PubMed ID: 17021990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Case Report.
    Sharma P; Sharma E; Neupane SP; Dahal S; Dahal S
    J Investig Med High Impact Case Rep; 2018; 6():2324709618820873. PubMed ID: 30622993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.
    Quintanilha JCF; Visacri MB; Amaral LS; Lima CSP; Cintra ML; Moriel P
    BMC Cancer; 2017 Dec; 17(1):831. PubMed ID: 29212535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
    Ahya VN; McShane PJ; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Garrity E; Alex CG; Bag R; DeOliveira NC; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Bhorade S
    J Heart Lung Transplant; 2011 Feb; 30(2):175-81. PubMed ID: 20947384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytoclastic vasculitis associated with clarithromycin.
    Gavura SR; Nusinowitz S
    Ann Pharmacother; 1998 May; 32(5):543-5. PubMed ID: 9606474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.